全文获取类型
收费全文 | 25185篇 |
免费 | 2543篇 |
国内免费 | 521篇 |
专业分类
耳鼻咽喉 | 778篇 |
儿科学 | 390篇 |
妇产科学 | 220篇 |
基础医学 | 2011篇 |
口腔科学 | 1150篇 |
临床医学 | 1703篇 |
内科学 | 1649篇 |
皮肤病学 | 291篇 |
神经病学 | 706篇 |
特种医学 | 3307篇 |
外国民族医学 | 13篇 |
外科学 | 5993篇 |
综合类 | 2834篇 |
现状与发展 | 2篇 |
一般理论 | 1篇 |
预防医学 | 1583篇 |
眼科学 | 286篇 |
药学 | 2568篇 |
31篇 | |
中国医学 | 361篇 |
肿瘤学 | 2372篇 |
出版年
2024年 | 49篇 |
2023年 | 492篇 |
2022年 | 822篇 |
2021年 | 1159篇 |
2020年 | 1230篇 |
2019年 | 1066篇 |
2018年 | 1091篇 |
2017年 | 1040篇 |
2016年 | 994篇 |
2015年 | 908篇 |
2014年 | 1820篇 |
2013年 | 1987篇 |
2012年 | 1518篇 |
2011年 | 1701篇 |
2010年 | 1284篇 |
2009年 | 1213篇 |
2008年 | 1241篇 |
2007年 | 1190篇 |
2006年 | 1016篇 |
2005年 | 863篇 |
2004年 | 753篇 |
2003年 | 604篇 |
2002年 | 486篇 |
2001年 | 443篇 |
2000年 | 359篇 |
1999年 | 344篇 |
1998年 | 297篇 |
1997年 | 279篇 |
1996年 | 223篇 |
1995年 | 214篇 |
1994年 | 192篇 |
1993年 | 147篇 |
1992年 | 127篇 |
1991年 | 108篇 |
1990年 | 107篇 |
1989年 | 113篇 |
1988年 | 96篇 |
1987年 | 72篇 |
1986年 | 72篇 |
1985年 | 99篇 |
1984年 | 86篇 |
1983年 | 47篇 |
1982年 | 64篇 |
1981年 | 57篇 |
1980年 | 50篇 |
1979年 | 43篇 |
1978年 | 14篇 |
1977年 | 25篇 |
1976年 | 18篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
《Molecular therapy》2022,30(5):1885-1896
- Download : Download high-res image (90KB)
- Download : Download full-size image
3.
4.
Guoliang Zhang & Tao Xiong 《Communications In Computational Physics》2022,32(1):126-155
We propose a high order finite difference linear scheme combined with a
high order bound preserving maximum-principle-preserving (MPP) flux limiter to
solve the incompressible flow system. For such problem with highly oscillatory structure but not strong shocks, our approach seems to be less dissipative and much less
costly than a WENO type scheme, and has high resolution due to a Hermite reconstruction. Spurious numerical oscillations can be controlled by the weak MPP flux
limiter. Numerical tests are performed for the Vlasov-Poisson system, the 2D guiding-center model and the incompressible Euler system. The comparison between the linear
and WENO type schemes, with and without the MPP flux limiter, will demonstrate the
good performance of our proposed approach. 相似文献
5.
Guo-Quan Shi Huajun Zhu & Zhen-Guo Yan 《Communications In Computational Physics》2022,31(4):1215-1241
A priori subcell limiting approach is developed for high-order flux reconstruction/correction procedure via reconstruction (FR/CPR) methods on two-dimensional unstructured quadrilateral meshes. Firstly, a modified indicator based on
modal energy coefficients is proposed to detect troubled cells, where discontinuities
exist. Then, troubled cells are decomposed into nonuniform subcells and each subcell has one solution point. A second-order finite difference shock-capturing scheme
based on nonuniform nonlinear weighted (NNW) interpolation is constructed to perform the calculation on troubled cells while smooth cells are calculated by the CPR
method. Numerical investigations show that the proposed subcell limiting strategy on
unstructured quadrilateral meshes is robust in shock-capturing. 相似文献
6.
《Vaccine》2022,40(30):4038-4045
PurposeAs protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evaluate post-booster seroconversion.MethodsA prospective observational study conducted in Maccabi Healthcare Services. Serial SARS-CoV-2 Spike IgG tests, 1,2,3 and 6 months following the second vaccine dose and one month following the third were obtained. Neutralizing antibody levels were measured in a subset of participants. Per individual SARS-CoV-2 Spike IgG titer ratios were calculated one month after the booster administration compared to titers one month following the second dose and prior to booster.ResultsAmong 110 participants, 56 (51%) were women. Mean age was 61.7 ± 1.9 years and 66 (60%) were immunocompromised. One month after third dose, IgG titers were induced 7.83 (95 %CI 5.25–11.67) folds and 2.40 (95 %CI 1.90–3.03) folds compared to one month after the second, in the immunocompromised and immunocompetent groups, respectively. Of the 17 immunocompromised participants who were seronegative after the second dose, 4 (24%) became seropositive following the third. Comparing the titers prior to the third dose, an increase of 50.7 (95 %CI 32.5–79.1) fold in the immunocompromised group and 25.7 (95 %CI 19.1–34.7) fold in and immunocompetent group, was observed.ConclusionA third BNT162b2 vaccine elicited robust humoral response, superior to the response observed following the second, among immunocompetent and immunocompromised individuals. 相似文献
7.
8.
9.
10.